[Effect of Aldadiene potassium on pulmonary gas exchange in chronic obstructive pulmonary diseases].
D000328:Adult; D000368:Aged; D001249:Asthma / Q000097:blood / Q000188:drug therapy*; D001991:Bronchitis / Q000097:blood / Q000188:drug therapy*; D002245:Carbon Dioxide / Q000097:blood; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008168:Lung / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D013148:Spironolactone / Q000627:therapeutic use*
D002245:Carbon Dioxide; D013148:Spironolactone; D010100:Oxygen
Uber den Einfluss von Aldadiene-Kalium auf den pulmonalen Gaswechsel bei chronisch obstruktiven Lungenerkrankungen.